The Use of Hyperbaric Oxygen Therapy in Ophthalmology

Survey of Ophthalmology

Volumn 53, Issue 2, 2008, Pages 112-120

  Oguz, Halit ^a   Sobaci, Gungor ^b  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

cellular effect; cost; evidence based medicine; eye diseases; hyperbaric oxygen therapy; side effect

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

CATARACT; CORNEA EDEMA; EYE CARE; EYE DISEASE; GLAUCOMA; HEALTH CARE COST; HUMAN; HYPERBARIC OXYGEN; INTRAOCULAR PRESSURE; MUCORMYCOSIS; MYOPIA; NECROSIS; OXYGEN TOXICITY; PRIORITY JOURNAL; PTERYGIUM; RETINA ARTERY OCCLUSION; RETINA DETACHMENT; RETINA DISEASE; RETINA MACULA CYSTOID EDEMA; RETINA VEIN OCCLUSION; RETINITIS PIGMENTOSA; REVIEW; SCLERA DISEASE; SICKLE CELL ANEMIA; VASOCONSTRICTION; VITREORETINOPATHY;

EYE DISEASES; HUMANS; HYPERBARIC OXYGENATION; OPHTHALMOLOGY;

EID: 40749095255     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2007.12.002     Document Type: Review

References (81)

1. Aisenbrey S., Krott R., Heller R., et al. Hyperbaric oxygen therapy in retinal artery occlusion. Ophthalmologe 97 (2000) 461-467
2. Arnold A.C., Hepler R.S., Lieber M., and Alexander J.M. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 122 (1996) 535-541
3. Bayer A., Mutlu F.M., and Sobaci G. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis. Ophthalmic Surg Lasers 33 (2002) 58-61
4. Bayer A., Mutlu F.M., and Sobaci G. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis. Ophthalmic Surg Lasers 32 (2001) 490-493
5. Beiran I., Goldenberg I., Adir Y., et al. Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol 11 (2001) 345-350
6. Bell S., and Mahoney L. Mucormycosis: a case study. Crit Care Nurse 20 (2000) 18-23
7. Bennett M., and Heard R. Hyperbaric oxygen therapy for multiple sclerosis. Cochrane Database Syst Rev 1 (2004) CD003057
8. Bojic L., Ivanisevic M., and Gosovic G. Hyperbaric oxygen therapy in two patients with non-arteritic anterior optic neuropathy who did not respond to prednisone. Undersea Hyperb Med 29 (2002) 86-92
9. Bojic L., Kovacevic H., Andric D., et al. Hyperbaric oxygen dose of choice in the treatment of glaucoma. Arh Hig Rada Toksikol 44 (1993) 239-247
10. Bojic L., Racic G., Gosovic S., and Kovacevic H. The effect of hyperbaric oxygen breathing on the visual field in glaucoma. Acta Ophthalmol (Copenh) 71 (1993) 315-319
11. Borruat F.X., Schatz N.J., Glaser J.S., et al. Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy. J Clin Neuroophthalmol 13 (1993) 98-101
12. Buras J. Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin 38 (2000) 1-109
13. Butler Jr. F.K. Diving and hyperbaric ophthalmology. Surv Ophthalmol 39 (1995) 347-366
14. Chang Y.H., Chen P.L., Tai M.C., et al. Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy. Clin Experiment Ophthalmol 34 (2006) 584-589
15. Cuthbertson C.M., and Christophi C. Potential effects of hyperbaric oxygen therapy in acute pancreatitis. ANZ J Surg 76 (2006) 625-630
16. de Smet M.D., Carruthers J., and Lepawsky M. Anterior segment ischemia treated with hyperbaric oxygen. Can J Ophthalmol 22 (1987) 381-383
17. Dimova E.Y., Samoylenko A., and Kietzmann T. Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid Redox Signal 6 (2004) 777-791
18. Dumitru R. The hyperbaric method in the treatment of diabetic retinopathy, an alternative to laser therapy?. Oftalmologia 37 (1993) 12-16
19. Edremitlioglu M., Kilic D., Oter S., et al. The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage. Surg Today 35 (2005) 653-661
20. Erşanli{dotless} D., Yi{dotless}ldi{dotless}z S., and Ay H. [The efficacy of hyperbaric oxygen therapy on vision loss as a sequela occurring at the late period due to carbon monoxide poisoning]. T Oft Gaz (Turkish Journal of Ophthalmology) 33 (2004) 190-192
21. Evanger K., Haugen O.H., Irgens A., et al. Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood. Acta Ophthalmol Scand 82 (2004) 449-453
22. Ferguson B.J., Mitchell T.G., Moon R., et al. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 10 (1988) 551-559
23. Fledelius H.C., Jansen E.C., and Thorn J. Refractive change during hyperbaric oxygen therapy. A clinical trial including ultrasound oculometry. Acta Ophthalmol Scand 80 (2002) 188-190
24. Freilich D.B., and Seelenfreund M.H. Long-term follow-up of scleral buckling procedures with sickle cell disease and retinal detachment treated with the use of hyperbaric oxygen. Mod Probl Ophthalmol 18 (1977) 368-372
25. Gallagher K.A., Goldstein L.J., Thom S.R., and Veiazquez O.C. Hyperbaric oxygen and bone-marrow-derived endothelial progenitor cells in diabetic wound healing. Vascular 14 (2006) 328-337
26. Gallin-Cohen P.F., Podos S.M., and Yablonski M.E. Oxygen lowers intraocular pressure. Invest Ophthalmol Vis Sci 19 (1980) 43-48
27. Gill A.L., and Bell C.N. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. OJM 97 (2004) 385-395
28. Green M.O., and Brannen A.L. Hyperbaric oxygen therapy for beta-radiation-induced scleral necrosis. Ophthalmology 102 (1995) 1038-1041
29. Guy J., and Schatz N.J. Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy. Ophthalmology 93 (1986) 1083-1088
30. Haffty B.G., Hufrler R.A., and Peters L.G. Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: long-term tumor control and complications. Int J Radiat Oncol Biol Phys 45 (1999) 13-20
31. Hampson N., and Atik D. Central nervous system oxygen toxicity during routine hyperbaric oxygen therapy. Undersea Hyperb Med 30 (2003) 147-153
32. Herbstein K., and Murchland J.B. Retinal vascular changes after treatment with hyperbaric oxygen. Med J Aust 140 (1984) 728-729
33. Hirai T., Kimura S., and Mori N. Head and neck infections caused by streptococcus milleri group: an analysis of 17 cases. Auris Nasus Larynx 32 (2005) 55-58
34. Huang E.T., Twa M.D., Schanzlin D.J., et al. Refractive change in response to acute hyperbaric stress in refractive surgery patients. J Cataract Refract Surg 28 (2002) 1575-1580
35. Jackman S.V., and Thompson J.T. Effects of hyperbaric exposure on eyes with intraocular gas bubbles. Retina 15 (1995) 160-166
36. Jampol L.M., Orlin C., Cohen S.B., et al. Hyperbaric and transcorneal delivery of oxygen to the rabbit and monkey anterior segment. Arch Ophthalmol 106 (1988) 825-829
37. Jain K.K. HBO Therapy and Ophthalmology. In: Jain K.K. (Ed). Textbook of Hyperbaric Medicine (2004), Hogrefe & Huber, Göttingen ed 4, pp 383-96
38. Jansen E.C., and Nielsen N.V. Promising visual improvement of cystoid macular oedema by hyperbaric oxygen therapy. Acta Ophthalmol Scand 82 (2004) 485-486
39. Jurgenliemk-Schulz I.M., Hartman L.J., et al. Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial. Int J Radiat Oncol Biol Phys 59 (2004) 1138-1147
40. Jutter B., Scheinichen D., Barthsch S., et al. Lack of toxic side effects in neutrophils following hyperbaric oxygen. Undersea Hyperb Med 30 (2003) 305-311
41. Kajs-Wyllie M. Hyperbaric oxygen therapy for rhinocerebral fungal infection. J Neurosci Nurs 27 (1995) 174-181
42. Keynan Y., Yanir Y., and Shupak A. Hyperbaric therapy for bilateral visual loss during hemodialysis. Clin Exp Nephrol 10 (2006) 82-84
43. Kiryu J., and Ogura Y. Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica 210 (1996) 168-170
44. Krott R., Heller R., Aisenbrey S., and Bartz-Schmidt K.U. Adjunctive hyperbaric oxygenation in macular edema of vascular origin. Undersea Hyperb Med 27 (2000) 195-204
45. Kurok A.M., Kitaoka T., Taniguchi H., and Amemiya T. Hyperbaric oxygen therapy reduces visual field defect after macular hole surgery. Ophthalmic Surg Lasers 33 (2002) 200-206
46. Leach R.M., Rees P.J., and Wilmshurst P. ABC of oxygen: Hyperbaric oxygen therapy. BMJ 317 (1998) 1140-1143
47. Lecleire-Collet A., Muraine M., Menard J.F., and Brasseur G. Predictive visual outcome after macula-off retinal detachment surgery using optical coherence tomography. Retina 25 (2005) 44-53
48. Levy R.L., and Miller N.R. Hyperbaric oxygen therapy for radiation-induced optic neuropathy. Ann Acad Med Singapore 35 (2006) 151-157
49. Li H.K., Dejean B.J., and Tang R.A. Reversal of visual loss with hyperbaric oxygen treatment in a patient with Susac syndrome. Ophthalmology 103 (1996) 2091-2098
50. Lin Y.C., Yang C.M., and Lin C.L. Hyperbaric oxygen treatment in Purtscher's retinopathy induced by chest injury. J Chin Med Assoc 69 (2006) 444-448
51. Mathews M.K. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol 16 (2005) 341-345
52. Oguz H., Basar E., and Gurler B. Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Acta Ophthalmol Scand 77 (1999) 147-150
53. Oriani G., Magni R., Michael M., et al. Assessment of visual contrast sensitivity in hyperbaric oxygen. Undersea Hyperb Med 21 (1994) 387-390
54. Palmquist B.M., Fagerholm P.P., and Philipson B.T. Nuclear vacuoles in nuclear cataract. Acta Ophthalmol (Copenh) 64 (1986) 63-66
55. Palmquist B.M., Philipson B., and Barr P.O. Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol 68 (1984) 113-117
56. Park C.C., Park J.S., Goldinger J.M., et al. Hyperbaric oxygen effect on active Na+ transport across isolated toad skin. Undersea Biomed Res 17 (1990) 23-32
57. Price J.C., and Stevens D.L. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 90 5 Pt 1 (1980) 737-747
58. Prockop L.D., and Grasso R.J. Ameliorating effects of hyperbaric oxygenation on experimental allergic encephalomyelitis. Brain Res Bull 3 (1978) 221-225
59. Recupero S.M., Cruciani F., Picardo V., et al. Hyperbaric oxygen therapy in the treatment of secondary keratoendotheliosis. Ann Ophthalmol 24 (1992) 448-452
60. Ross W., Lavina A., Russell M., and Maberley D. The correlation between height of macular detachment and visual outcome in macula-off retinal detachments of less than or equal to 7 days' duration. Ophthalmology 112 (2005) 1213-1217
61. Rothfuss A., and Speit G. Investigations on the mechanism of hyperbaric oxygen (HBO)-induced adaptive protection against oxidative stress. Mutat Res 31 508 1-2 (2002) 157-165
62. Sakoda M, Ueno S, Kihara K, et al: A potential role of hyperbaric oxygen exposure through intestinal nuclear factor-kappaB. Crit Care Med 32:1722-9, 200
63. Schaal S., Beiran I., Rubinstein I., et al. Lenticular oxygen toxicity. Invest Ophthalmol Vis Sci 44 (2003) 3476-3484
64. Schmetterer L., Findl O., Strenn K., et al. Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans. Am J Physiol Regul Integr Comp Physiol 273 (1997) R2005-R2012
65. Sen C.K., Khanna S., Gordillo G., et al. Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm. Ann NY Acad Sci 957 (2002) 239-249
66. Sheffield P.J., and Desautels D.A. Hyperbaric and hypobaric chamber fires: a 73-year analysis. Undersea Hyperb Med 24 (1997) 153-164
67. Skogstad M., Bast-Pettersen R., Tynes T., et al. Treatment with hyperbaric oxygen. Illustrated by the treatment of a patient with retinitis pigmentosa. Tidsskr Nor Laegeforen 114 (1994) 2480-2483
68. Tezel G., and Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Invest Ophthalmol Vis Sci 45 (2004) 4049-4059
69. Thom S.R., Bhopale V., Fisher D., et al. Stimulation of nitric oxide synthesis in cerebral cortex due to elevated partial pressures of oxygen: an oxidative stress response. J Neurobiol 51 (2002) 85-100
70. Tibbles P.M., and Edelsberg J.S. Hyperbaric-oxygen therapy. N Engl J Med 334 (1996) 1642-1648
71. Troutbeck R., and Hirst L. Trends in beta irradiation for pterygium in Queensland. Clin Experiment Ophthalmol 31 (2003) 545
72. Van Hoesen K.B., Camporesi E.M., Moon R.E., Hage M.L., and Piantadosi C.A. Should hyperbaric oxygen be used to treat the pregnant patient for acute carbon monoxide poisoning? A case report and literature review. JAMA 261 (1989) 1039-1043
73. Vingolo E.M., Pelaia P., Forte R., et al. Does hyperbaric oxygen (HBO) delivery rescue retinal photoreceptors in retinitis pigmentosa?. Doc Ophthalmol 97 (1998-9) 33-39
74. Vucetic M., Jensen P.K., and Jansen E.C. Diameter variations of retinal blood vessels during and after treatment with hyperbaric oxygen. Br J Ophthalmol 88 (2004) 771-775
75. Wallace D.J., Silverman S., Goldstein J., and Hughes D. Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus 4 (1995) 172-175
76. Warren J., Sacksteder M.R., and Thuning C.A. Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents. J Immunol 121 (1978) 315-320
77. Warren J., Sacksteder M.R., and Thuning C.A. Therapeutic effect of prolonged hyperbaric oxygen in adjuvant arthritis of the rat. Arthritis Rheum 22 (1979) 334-339
78. Weinberger A.W., Siekmann U.P., Wolf S., et al. Treatment of acute central retinal artery occlusion (CRAO) by hyperbaric oxygenation therapy (HBO)-Pilot study with 21 patients. Klin Monatsbl Augenheilkd 219 (2002) 728-734
79. Yogaratnam J.Z., Laden G., Guvendik L., et al. Hyperbaric oxygen: a novel technology for modulating myocardial schemia-reperfusion via a single drug. Adv Ther 23 (2006) 528-533
80. Yohai R.A., Bullock J.D., Aziz A.A., and Markert R.J. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 39 (1994) 3-22
81. Zamboni W.A., Roth A.C., Russell R.C., et al. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 91 (1993) 1110-1123